Crossmark

B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphoma

Crossref DOI link: https://doi.org/10.1186/s13000-018-0717-9

Published Online: 2018-06-05

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Javier, Rodrigo

Shaikh, Nawal

Lesniak, Maciej S.

Sonabend, Adam

Stupp, Roger

Behdad, Amir

Horbinski, Craig http://orcid.org/0000-0001-8340-9992
License Information

Text and Data Mining valid from 2018-06-05
More Information

Article History

Received: 20 February 2018

Accepted: 25 May 2018

First Online: 5 June 2018

Ethics approval and consent to participate

: Not applicable.

: Written informed consent for publication of their clinical details and clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.